Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom.

导出 OA

翻译打印收藏纠错

第一作者： Lianne,Kearsley-Fleet

第一单位： Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

作者： Lianne,Kearsley-Fleet ^[1] ; Sunil,Sampath ^[1] ; Liza J,McCann ^[2] ; Eileen,Baildam ^[2] ; Michael W,Beresford ^[3] ; Rebecca,Davies ^[1] ; Diederik,De Cock ^[1] ; Helen E,Foster ^[4] ; Taunton R,Southwood ^[5] ; Wendy,Thomson ^[6] ; Kimme L,Hyrich ^[7]

作者单位： Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. ^[1] Clinical Academic Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust, UK. ^[2] Clinical Academic Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust, UK.;Institute of Translational Medicine (Child Health), University of Liverpool, Liverpool, UK. ^[3] Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.;Paediatric Rheumatology, Great North Children's Hospital, Newcastle upon Tyne, UK. ^[4] Institute of Child Health, University of Birmingham and Birmingham Children's Hospital, Birmingham, UK. ^[5] Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Faculty of Biologic, Medicine and Health, University of Manchester, Manchester, UK.;National Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. ^[6] Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.;National Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. ^[7]